Proteomics Market Research Reports & Industry Analysis
Proteomics is the study of the entire set of proteins expressed by a cell, tissue, or organism, including their structures, functions, and interactions. The global proteomics market is growing at a rapid rate and is facilitating advancements in diagnostics, personalized medicine, and drug development. To help inform your business strategy, MarketResearch.com offers a range of reports on the proteomics industry that have been produced by expert analysts at leading research firms.
Our Proteomics Market Research Collection
- Access proteomics market sizing data segmented by product, application, technology, end-user, and region.
- Understand the key growth drivers, challenges, and trends shaping this dynamic industry.
- Evaluate the competitive landscape including key market players, their operating segments, and business strategies.
Experience and Reliability
With over twenty years of experience in delivering top-notch market research, MarketResearch.com has earned the trust of prominent investment banks, consulting firms, and Fortune 500 companies. If you need assistance, our team of research specialists is ready to offer expert advice and suggestions to enhance your decision-making process. Browse our collection of proteomics market research reports today.
Proteomics Industry Research & Market Reports
-
Protein Chip Market, By Type (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays, Others), By Application (Antibody Characterization, Clinical Diagnostics, Proteomics, Others), By Detection Technique (Fluorescence, Chemiluminescence, Mass Spectrometry, Electrical, Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... a solid surface to create a microarray. These protein chips can be used for detecting expression levels of proteins, screening protein-protein interactions, monitoring protein modifications like phosphorylation and for prognosing diseases by identifying biomarkers. The ... Read More
-
The 2026-2031 World Outlook for Computational Biology
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Cellular and Biological Simulation Computational Biology
... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More
-
The 2026-2031 World Outlook for E-Coli In-Vitro Protein Expression Systems
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Albumin Plasma Protein Therapeutics
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Expression Proteomics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Cell Free Protein Expression Enzyme Engineering
... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More
-
The 2026-2031 World Outlook for Cell Free Protein Expression
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Expression Vectors
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
Growth Factors (Blood and Tissue)
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Interferons, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$78.2 Billion by ... Read More
-
Proteomics
... 10.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth in ... Read More
-
G-Protein Coupled Receptors (GPCRs)
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Cell Lines, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.9 Billion by the ... Read More
-
Fusion Proteins
... CAGR of 4.7% over the analysis period 2024-2030. Metabolic Disorders, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.9 Billion by the end of the analysis ... Read More
-
Sample Preparation
... CAGR of 4.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
Protein Therapeutics
... CAGR of 5.8% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$284.7 Billion by the end of the analysis ... Read More
-
In Vitro Protein Expression Systems
... Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. E-Coli, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$162.9 Million by ... Read More
-
Glycomics / Glycobiology
... at a CAGR of 16.9% over the analysis period 2024-2030. Enzymes, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Electron Microscopy and Sample Preparation
... Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Industrial, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$3.2 Billion by ... Read More
-
Computational Biology
... CAGR of 18.0% over the analysis period 2024-2030. Drug Discovery & Disease Modelling, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$15.7 Billion by the end ... Read More
-
Up-Regulated Protein
... CAGR of 6.2% over the analysis period 2024-2030. Diagnostic Labs, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$300.9 Million by the end of the analysis ... Read More
-
Protein Extracts from Single Cell Protein and Other Conventional Sources
... Billion in the year 2024, is expected to reach US$44.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Plant Protein Extract, one of the segments analyzed in the report, ... Read More
-
Plasma Protein Therapeutics
... at a CAGR of 4.8% over the analysis period 2024-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$9.3 Billion by the end of the ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by ... Read More
-
Cell Free Protein Expression
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Protein-Protein Interaction, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$193.3 Million by the ... Read More
-
Metabolomics
... 11.7% over the analysis period 2024-2030. Biomarker Discovery Application, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$3.3 Billion by the end of the analysis period. ... Read More
Research Assistance
